-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Sarepta Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q3 2024.
- Sarepta Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $43.5M, a 9.56% decline year-over-year.
- Sarepta Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $180M, a 3.68% decline year-over-year.
- Sarepta Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $183M, a 21.7% decline from 2022.
- Sarepta Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $233M, a 105% increase from 2021.
- Sarepta Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $114M, a 5.43% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)